US Drug Recall Register

FDA Drug Recalls

1,709 recalls · Class III, newest first

Class III · Low risk Terminated

Fludeoxyglucose F 18 Injection

Reason Failed Impurities/Degradation Specifications; out of specification result for Acetonitrile residual solvent

Lantheus MI Radipharmaceuticals Inc. NDC 11994-015-01 D-0942-2017
Class III · Low risk Terminated

Nystatin Oral Suspension

Reason Failed Impurities/Degradation Specifications: Presence of an impurity peak that exceeds approved specification.

VistaPharm, Inc. NDC 66689-008-02 D-0869-2017
Class III · Low risk Terminated

Montelukast Sodium Oral Granules

Reason Failed Impurities/Degradation Specifications; out of specification results for Sulphoxide Impurity and Total Impurities

Mylan Pharmaceuticals Inc. NDC 0378-6040-93 D-0920-2017
Class III · Low risk Terminated

Benzonatate capsules

Reason Failed Stability Specifications: Out of Specification results obtained for preservative Methylparaben content.

Strides Pharma INC NDC 64380-713-06 D-0858-2017
Class III · Low risk Terminated

Hydrocortisone Lotion

Reason Superpotent Drug: above specification for the assay.

Vintage Pharmaceuticals LLC, DBA Qualitest Pharmaceuticals NDC 0603-7785-52 D-0859-2017
Class III · Low risk Terminated

Amlodipine Besylate Tablet

Reason PRESENCE OF FOREIGN TABLETS/CAPSULES: A 2.5 mg Amlodipine Besylate tablet was found co-mingled with 10 mg Amlodipine Besylate tablets in a bottle labeled as Amlodipine Besylate 10 mg.

Ascend Laboratories LLC NDC 67877-199-10 D-1134-2017
Class III · Low risk Terminated

Minivelle

Reason Defective Delivery System: Out of specification for peel force from the release liner specification during stability testing at 18M 25C/60%RH.

Noven Pharmaceuticals, Inc. D-0923-2017
Class III · Low risk Terminated

Acyclovir Tablets

Reason Presence of Foreign Substance: human hair melded into tablet.

Hetero USA Inc NDC 31722-778-01 D-0897-2017
Class III · Low risk Terminated

IC-Green

Reason Product is being recalled due to low pH value.

Akorn, Inc. NDC 17478-701-02 D-0697-2017
Class III · Low risk Terminated

Children's Cetirizine Hydrochloride Chewable Tablets

Reason Failed Tablet/Capsule Specifications: out of specification results for increased tablet hardness.

Sun Pharmaceutical Industries, Inc. NDC 47335-343-83 D-0857-2017
Class III · Low risk Terminated

Zinc Oxide Paste 25%

Reason Labeling: Error on Declared Strength: Error is due to an incorrect value in the Drug Facts Panel. The correct strength is displayed on the primary container.

Fagron, Inc NDC 51522-0694-5 D-0695-2017
Class III · Low risk Terminated

Allergy Relief Diphenhydramine HCl 25 mg

Reason Subpotent: This product is being recalled due to low out of specification assay results at the 9 month time point.

P & L Development, LLC NDC 36800-483-24 D-0694-2017
Class III · Low risk Terminated

Desoximetasone Ointment USP

Reason Superpotent Drug

Teligent, Inc. NDC 52565-030-15 D-0787-2017
Class III · Low risk Terminated

Doxercalciferol Capsules 0.5mcg

Reason Failed Tablet/Capsule Specifications; during an internal inspection, capsules were found with illegible print.

West-Ward Columbus, Inc. NDC 0054-0338-19 D-0651-2017
Class III · Low risk Terminated

PrednisoLONE Oral Solution USP

Reason Failed Stability Specifications

Teva Pharmaceuticals USA NDC 0093-6118-87 D-0703-2017
Class III · Low risk Terminated

Olanzapine Tablets

Reason Failed Impurities/Degradation Specifications: out of specification results for the related substances test parameter (impurities).

Sun Pharmaceutical Industries, Inc. NDC 62756-556-83 D-0702-2017
Class III · Low risk Terminated

Olanzapine Tablets

Reason Failed Impurities/Degradation Specifications: out of specification results for the related substances test parameter (impurities).

Sun Pharmaceutical Industries, Inc. NDC 62756-554-83 D-0701-2017
Class III · Low risk Terminated

Olanzapine Tablets

Reason Failed Impurities/Degradation Specifications: out of specification results for the related substances test parameter (impurities).

Sun Pharmaceutical Industries, Inc. NDC 62756-553-83 D-0700-2017
Class III · Low risk Terminated

Olanzapine Tablets

Reason Failed Impurities/Degradation Specifications: out of specification results for the related substances test parameter (impurities).

Sun Pharmaceutical Industries, Inc. NDC 62756-551-18 D-0699-2017
Class III · Low risk Terminated

Isopto Carpine

Reason Failed Impurities/Degradation Specifications.

Novartis Pharmaceuticals Corp. NDC 0998-0206-15 D-0678-2017